Health | 467 hits | Nov 14 6:21 pm | Posted by: Scape
Belgium has decided to temporarily ban the use of Novo Nordisk's diabetes drug Ozempic as a weight loss treatment amid a shortage of the medicine, according to a royal decree published in the country's Official Gazette on Tuesday.
Comments
You need to be a member of CKA and be logged into the site, to comment on news.